about
Comprehensive review of BAP1 tumor predisposition syndrome with report of two new casesDislocated Crystalline Lens Mimicking Metastatic Endometrial Cancer.Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma PatientsSpectral domain optical coherence tomography in a murine retinal detachment model.Focal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma.Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate.Basic fibroblast growth factor impact on retinoblastoma progression and survivalGermline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.Diagnostic challenges in retinitis pigmentosa: genotypic multiplicity and phenotypic variability.A chick model of retinal detachment: cone rich and novelMonosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival.A case of vogt-koyanagi-harada syndrome with persistent dyspnea secondary to laryngeal edema.Required reduction in dose of chemotherapy for retinoblastoma due to down syndrome-associated chemosensitivity.Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous MelanomaLong-term survivors with metastatic uveal melanoma.Bilateral optic neuropathy following bite from brown recluse spider (Loxosceles reclusa)Activation of glucocorticoid receptors in Müller glia is protective to retinal neurons and suppresses microglial reactivity.Multimodal Imaging and Clinicopathologic Correlation in Primary Uveal LymphomaBlood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculatureCharles Bonnet syndrome and Terson's syndrome from subarachnoid hemorrhage: good news from bad news.Genetic markers of pigmentation are novel risk loci for uveal melanoma.Germline BAP1 mutations misreported as somatic based on tumor-only testingLong-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.Retinal tumor imaging and volume quantification in mouse model using spectral-domain optical coherence tomography.Atypical cat scratch disease with vitritis, serous macular detachment, neuroretinitis, and retrobulbar optic neuritis.Optic disc edema from remote uveal melanoma.Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimental retinal detachment.Screening and characterization of Staphylococcus aureus from ophthalmology clinic surfaces: a proposed surveillance tool.Toward failure analyses in systems biology.Intravitreal devices for the treatment of vitreous inflammation.Systemic treatment of vitreous inflammation.Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.Breaking bad news: A communication competency for ophthalmology training programs.Germline BAP1 alterations in familial uveal melanoma.Endogenous endophthalmitis and osteomyelitis associated with interleukin 17 inhibitor treatment for psoriasis in a patient with diabetes.Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimensTumor volume reduction using combined phacoemulsification and intravitreal triamcinolone injection for the management of cataract with treated uveal melanoma and atypical nevi.Management of fluocinolone implant dissociation during implant exchange.
P50
Q28397229-F3E1150A-B55D-400E-915D-AA2C79C2F646Q30374698-DB5BCA81-63F2-4B4C-B642-7E2F34EAE9CAQ30382522-6A22F769-3451-4D21-88B7-628AC944C826Q33527619-AC6A9F57-1A0D-4F36-B083-FC8E27D39B48Q33564691-3F8A0D97-AA42-4108-B646-99CEB0F2F40DQ33697377-4EC9BAC0-EF68-4659-AA8B-7DCC6C10E78CQ33845565-D39762F7-BF3A-470C-B52D-A0E7D86D7F44Q33938157-FA0A65BF-9D04-45D6-8038-26377F5554C0Q34070005-545EBF62-3EAD-4674-B32A-4C05BD951C8AQ34218657-5D868137-4A8C-448F-BE7B-71D0AD09752DQ34237307-4C5778B7-C360-4B47-8FA3-E0CB862DD5B2Q34412316-B72AE565-1EB2-40EC-8337-68E25DFBF2F3Q34961980-88F18384-73F5-4AA3-AE16-70374BF36CEAQ35081507-297AF6CA-8BC6-4E7B-A198-496696EFD613Q35413171-19836ECD-5112-4FEA-A26E-C808C0BB7A37Q35956339-2D7AA14B-BA4D-42B8-9B5A-29B0036F9006Q36088202-BA884BA6-8377-47F1-A0BF-8624E439466FQ36161847-BA5B781E-B044-4D93-8EF5-DCB0572B1403Q36278871-DDB10537-86B1-48B0-8244-AEE599897371Q36566518-C2787245-7036-42D4-84FD-6B2F85A6EDC3Q37020248-F89F3931-192A-4BE8-842A-3E734C7A4ADAQ37087246-1305C3B3-3AA7-4313-9E97-ACAA07D6191FQ37157463-3D9D08C0-6C58-4FA0-8863-807D44CB7D44Q37171825-D3361548-5DD3-4ACA-A4A5-715050748FD1Q37188699-D444F8DA-00D2-4517-ADF8-00AD34CA3B81Q37283524-2795A09F-9E64-4478-982A-36C0E2DA1FC6Q37312064-05DC7124-6042-4A05-97D8-1AFE8FDA416AQ37632849-EC803706-0DDB-4470-80F0-FD6A642F773DQ37691345-560F3AEE-1535-424C-B8AB-A898B2AB203AQ37691496-EACE40DC-8A97-43F2-A3C0-930B073B5FE0Q37788040-E91367C9-10D8-4047-A062-17A44C972F9DQ38044373-AFB0F873-1B51-491F-AF50-B3E69FE21546Q38048774-3977FA18-4CDC-471E-AD90-5EBBF42BD81CQ38201794-9AF77AFF-1DE6-46FE-9D53-39AA9D634357Q38802838-982B0092-3648-415D-8BF9-21521D7A0C9DQ38805682-F28304A0-1F6F-4549-BC49-E9AEBC3AFC7DQ40151485-BD421E68-9AB6-4FE2-92CB-36A896F9BBEEQ41983928-F43472A7-F510-45FC-9F67-CDAB695A3B23Q42442153-D05C73DD-8DD9-4676-9DB8-3D87822AA73EQ43276860-DE84818B-8DB6-42EE-8567-1F6CE8970F77
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Colleen M. Cebulla
@ast
Colleen M. Cebulla
@en
Colleen M. Cebulla
@es
Colleen M. Cebulla
@nl
Colleen M. Cebulla
@sl
type
label
Colleen M. Cebulla
@ast
Colleen M. Cebulla
@en
Colleen M. Cebulla
@es
Colleen M. Cebulla
@nl
Colleen M. Cebulla
@sl
prefLabel
Colleen M. Cebulla
@ast
Colleen M. Cebulla
@en
Colleen M. Cebulla
@es
Colleen M. Cebulla
@nl
Colleen M. Cebulla
@sl
P106
P1153
23476318200
P21
P31
P496
0000-0002-5636-4968